Turner MedTech, a leading medical device contract manufacturer, has entered into a Memorandum of Understanding (MOU) with PollenSense to produce a cutting-edge pollen detection device designed to help allergy sufferers better manage their symptoms.
The partnership leverages Turner MedTech's manufacturing expertise to bring the PollenSense device to market, utilizing advanced sensor technology that provides real-time pollen monitoring. This innovative solution promises to offer users hyperlocal, precise information about pollen levels in their immediate environment.
Charles Jensen, VP/GM of Turner MedTech, expressed confidence in the company's ability to manufacture the device to high-quality standards. The collaboration is expected to create new job opportunities and contribute to economic growth in Utah, with initial production units planned for Q2 2025.
The PollenSense device represents a significant advancement in allergy tracking technology, moving beyond traditional manual monitoring methods. By providing instantaneous, location-specific pollen data, the device could dramatically improve quality of life for individuals with allergies, enabling more proactive symptom management.
David Brent Noel, CEO of PollenSense, highlighted the strategic value of partnering with Turner MedTech's experienced manufacturing team as they scale up production of their innovative technology.
